Comparison of the SUNRISE© Device With Ventilatory Polygraphy for the Diagnosis of Obstructive Sleep Apnea Hypopnea Syndrome: Collection of Preliminary Data
Key facts
- Who runs it
- Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 37 people enrolled
- Started
- 19 Jun 2024
- Ended
- 28 Feb 2025
- Type of study
- Observational
- Treatments tested
- SUNRISE© device
- Record updated
- 29 May 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Patient aged 18 or over
- Patient with a smartphone (Android or iOS) with Bluetooth and Internet connection and able to use the mobile application associated with the Sunrise© medical device
- Patient having a scheduled exploration by ventilatory polygraphy
- Non-opposition to participation in the research
Who cannot take part
- Patient suffering from a psychiatric pathology or with a history of behavioral disorders
- Patient already treated for OSAHS
- Patient refusing to cut his beard (if too abundant to wear the Sunrise© device)
- Patient suffering from a pathology affecting the rotation of the condyle in the temporomandibular joint
- Patient deprived of liberty by judicial or administrative decision
- Patients under court protection or legal guardianship
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Additional data on screening for obstructive sleep apnea/hypopnea syndrome (OSAHS) in patients with co-morbidities, such as diabetics and those with chronic respiratory diseases would enable current recommendations to evolve, with a view to promoting the widespread use of simplified techniques for OSAHS screening, particularly in patients with cardiorespiratory co-morbidities.
Read full original descriptionShow less
The primary objective of this observational multicentric pilot study is to compare the performance of the Sunrise® medical device with that of ventilatory polygraphy as part of routine screening for OSAHS in diabetic patients followed up in the diabetology department of the Strasbourg University Hospital, and in patients followed up in the pneumology consultation department of Mulhouse Hospital (GHRMSA).
The group in the trial
- Suspected OSAHS
Treatment: SUNRISE© device
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 29 May 2026